Medroxyprogesterone improves cardiac autonomic control in postmenopausal women with respiratory insufficiency.
D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy*; D003271:Contraceptive Agents, Female / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D008875:Middle Aged; D017698:Postmenopause; D011446:Prospective Studies; D012131:Respiratory Insufficiency / Q000150:complications*; D016037:Single-Blind Method
D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate